Development of a novel PRO instrument for use in familial chylomicronemia syndrome
Citation:
Journal of Patient-Reported Outcomes
2021
5:72
Supporter
Ionis Pharmaceuticals is exploiting its expertise in RNA to discover and develop novel human therapeutic drugs for patients. The company is also developing a biosensor to identify infectious organisms.
Membership discount for your BMC & SpringerOpen article processing charges (APCs)
As an affiliated author, a membership discount is available on your APC.
Please follow the submission guidelines to benefit from this membership discount.